Atrial Fibrillation: all 3,957 studies
Page 31 of 40. Open to participants first (933), then studies with results posted, then the rest; newest registration first within each.
- A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation ApproachCompletedNCT02654353Phase 4
- The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation PatientsStatus unknownNCT02646267Phase 4
- Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease StudyStatus unknownNCT02642419Phase 4
- Follow-up of Kryptogenic Stroke Patients With Implantable vs. Non-invasive Devices to Detect Atrial Fibrillation.CompletedNCT02641678
- APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM StudyCompletedNCT02640222
- Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)Status unknownNCT02639793Phase 4
- Addition of Six Short Lines on Pulmonary Vein IsolationCompletedNCT02637453Not applicable
- Clinical Decision Support for Stroke Prevention in Atrial FibrillationActive, not recruitingNCT02635685Not applicable
- What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.Status unknownNCT02635230
- Impact of the Relaxation Response Resiliency Program on Patients With Atrial FibrillationCompletedNCT02634697Not applicable
- GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life EvidenceStatus unknownNCT02633982
- Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial FibrillationStatus unknownNCT02633774Not applicable
- Medical and Surgical Hybrid Treatment of Atrial Fibrillation.CompletedNCT02630914Not applicable
- Pulmonary Vein Reconnection Following Ablation Index-guided Ablation: a Success EvaluationStatus unknownNCT02628730Not applicable
- Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise TrainingCompletedNCT02627183
- Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve ImplantationCompletedNCT02626871
- A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial FibrillationCompletedNCT02623517
- Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial FibrillationStatus unknownNCT02623049
- Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac SurgeryStatus unknownNCT02617069Phase 2/3
- Burden of Illness in Atrial FibrillationCompletedNCT02615587
- Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial FibrillationWithdrawnNCT02614521
- Effect of Cryoballoon and RF Ablation on Left Atrial FunctionStatus unknownNCT02611869Not applicable
- Atrial Fibrillation Patient Preference StudyCompletedNCT02611635
- Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic StrokeCompletedNCT02610803
- Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control StrategiesCompletedNCT02610153
- Anticoagulation Preference by AF Patients StudyCompletedNCT02607371
- Stroke Lesion Pattern on MRI and Atrial FibrillationCompletedNCT02606890
- Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery DiseaseTerminatedNCT02606552Phase 4
- Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)Active, not recruitingNCT02602457Not applicable
- Improving Quality by Maintaining Accurate Problems in the EHRCompletedNCT02596087Not applicable
- Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in PatientsStatus unknownNCT02592980Phase 4
- A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In DenmarkCompletedNCT02591732
- Left Atrial Thrombus Reduction - Effect of Dabigatran Versus PhenprocoumonStatus unknownNCT02591225Phase 4
- PV Cryoablation Efficacy (COR ADVANCE Study)CompletedNCT02588183Not applicable
- Remote MAGNetic Catheter Ablation for Atrial FibrillationCompletedNCT02587624
- A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With HypertensionCompletedNCT02585076
- Assessment of Thrombotic Status in Patients With Atrial FibrillationStatus unknownNCT02583971
- Feasibility Study of a Left Atrial Appendage Closure Device in Patients With Atrial FibrillationStatus unknownNCT02583178Not applicable
- COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AFWithdrawnNCT02582190Phase 3
- Serial ECG Versus Holter to Detect Atrial Fibrillation in Elderly Ischemic Stroke PatientsCompletedNCT02578979Not applicable
- ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1CompletedNCT02569528
- Safe Use of New Oral Anticoagulants in Ablation for Atrial FibrillationCompletedNCT02569255
- Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial FibrillationCompletedNCT02565693Phase 2
- BIO.MASTER.BioMonitor 2 StudyCompletedNCT02565238
- Effects of Mindfulness on Atrial FibrillationStatus unknownNCT02564302Not applicable
- Apixaban in Atrial Fibrillation RegistryCompletedNCT02563639
- Association of Dipping Pattern or Early Morning Surge of BP With Asymptomatic Episodes of Paroxysmal Atrial Fibrillation in Subjects With Hypertension (DIMOSPAF)Status unknownNCT02563379
- Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial FibrillationCompletedNCT02562404
- Effect of Left Atrial Appendage Excision on Procedure Outcome in Patients With Persistent and Long-standing Persistent Atrial Fibrillation Undergoing Surgical AblationStatus unknownNCT02562391Phase 2
- An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care CentersCompletedNCT02559232
- CoolLoop Paroxysmal Atrial FibrillationTerminatedNCT02553239Not applicable
- Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus RivaroxabanStatus unknownNCT02549963Phase 4
- Impact of Anxiety on Cardiac Substrate Modification in Women With Atrial Fibrillation Undergoing Catheter AblationStatus unknownNCT02547584Not applicable
- Determining the True Incidence of Atrial Fibrillation Before and After Lung ResectionTerminatedNCT02547168Not applicable
- Pleotropic Effect of New Oral AnticoagulantsStatus unknownNCT02544932Phase 3
- High Sensitivity Cardiac Troponin T in Patients With Atrial Fibrillation Admitted to an Emergency Department (ED)CompletedNCT02542189
- Multi-Channel Esophageal ECG Signal ClassificationCompletedNCT02541175
- Bioequivalence Study of RivaroxabanCompletedNCT02537457Phase 1
- Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male SubjectsCompletedNCT02537405Phase 1
- Atrial Fibrillation Screening With a Smartphone Device and iECG ApplicationWithdrawnNCT02534532
- Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial FibrillationCompletedNCT02533843Phase 3
- Canadian WATCHMAN RegistryStatus unknownNCT02533752
- Spinal Cord Stimulation to Treat Post-operative Atrial FibrillationTerminatedNCT02530203Not applicable
- Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter Ablation of Atrial FibrillationCompletedNCT02529319Not applicable
- Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial FibrillationCompletedNCT02528604Phase 4
- Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation Using Functional MRI (fMRI)CompletedNCT02524028
- Utilizing a Novel Method to Map Sources of Atrial FibrillationCompletedNCT02523534Not applicable
- Subclinical Postoperative Atrial FibrillationStatus unknownNCT02522364Not applicable
- Safety and Performance Study to Evaluate Access to Pulmonary Veins for Treatment of Paroxysmal AFCompletedNCT02521896Not applicable
- Unipolar Atrial Electrogram Modification Combined to the Contact Force Sensing Technology for Pulmonary Vein IsolationCompletedNCT02520960
- Atrial Fibrillation General RegistryCompletedNCT02518984
- Hybrid Atrial Fibrillation Ablation RegistryCompletedNCT02516033
- Foresight Intracardiac Echocardiography (ICE) SystemCompletedNCT02514876Early Phase 1
- aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial FibrillationStatus unknownNCT02513797Not applicable
- Clinical Relevance of Microbleeds In StrokeCompletedNCT02513316
- Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular FunctionStatus unknownNCT02509754Phase 4
- Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial FibrillationTerminatedNCT02507986Not applicable
- Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIACompletedNCT02507856
- ELR Monitoring Against Permanent Pacemaker in Atrial FibrillationStatus unknownNCT02506621Not applicable
- Laser Ablation Study for trEatment of atRial Fibrillation (LASER)CompletedNCT02504567Phase 4
- Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial FibrillationStatus unknownNCT02504177Not applicable
- Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer CenterCompletedNCT02502396
- Study of Statin for Reduction of Postoperative Paroxysmal Atrial FibrillationStatus unknownNCT02502110Phase 4
- Non-invasive Characterization of the Mechanisms of Atrial Fibrillation MaintenanceCompletedNCT02497248
- Physiotherapist Led Group-exercise Compared Physical Activity on Prescription, a 3 Months Follow-upCompletedNCT02493400
- Supervised Exercise Compared to PAP in Patients With Permanent Atrial FibrillationCompletedNCT02493387Not applicable
- Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese PopulationStatus unknownNCT02493075Phase 1/2
- Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Patients With Persistent AFStatus unknownNCT02492256Phase 2
- A Prospective Study of Different Digoxin Treatment Regimens in Egyptian HospitalCompletedNCT02489786Phase 4
- Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2CompletedNCT02488421
- Real-Life Evidence on Stroke Prevention in SPAFCompletedNCT02485873
- PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership CohortActive, not recruitingNCT02485288
- LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of StrokeCompletedNCT02478294
- a Novel Individualized Substrate Modification Approach for the Treatment of Long-standing Persistent Atrial FibrillationStatus unknownNCT02477592Not applicable
- Comparison of Operator-guided and Automatic Algorithm-guided Atrial Fibrillation AblationCompletedNCT02476227Not applicable
- Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial FibrillationStatus unknownNCT02475642Phase 4
- Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium EnlargementCompletedNCT02474108Not applicable
- WATCHMAN Implantation During Hybrid AblationCompletedNCT02471131Not applicable
- An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care CentresCompletedNCT02470767
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)CompletedNCT02468102